MOTS-c: The Mitochondrial Peptide That Links Exercise, Metabolism, and Aging

Comprehensive review article synthesizing published research on MOTS-c's molecular mechanisms, including its retrograde signaling to the nucleus, AMPK pathway activation, metabolic effects, stress homeostasis roles, and connections to aging-related diseases.

MOTS-c is part of a newly discovered class of mitochondrial-derived peptides that challenge the old view of mitochondria as simple energy factories. The fact that mitochondria produce signaling peptides that travel to the nucleus and regulate gene expression represents a fundamental shift in cell biology. For aging research specifically, MOTS-c is exciting because it connects exercise, metabolism, and stress resistance through a single molecular pathway — potentially explaining why exercise is so protective against age-related disease and opening new therapeutic possibilities.

MOTS-c belongs to a new class of mitochondrial-derived peptides (MDPs) discovered in the last decade. These peptides have rewritten the textbook on mitochondrial biology — showing that mitochondria don't just make energy but actively communicate with the rest of the cell to coordinate stress responses. MOTS-c in particular has become central to the 'exercise mimetic' concept: the idea that a molecule could replicate some of exercise's protective effects. While still mostly preclinical, MOTS-c research is informing new approaches to metabolic disease, neurodegeneration, and healthy aging.

As a review, this synthesizes existing research rather than presenting new data. Much of the MOTS-c research is preclinical (cell culture and animal studies). Human clinical data is limited. The precise mechanisms by which MOTS-c levels decline with age and how this contributes to disease are still being worked out. Therapeutic applications remain theoretical.